medigraphic.com
ISSN 1028-9933 (Electronic)

2022, Number 4

<< Back Next >>

RIC 2022; 101 (4)

Clinical profile of patients with chronic urticaria at the Main Military Hospital, Guinea-Bissau

Espinosa-Méndez K, Casado-Méndez PR, Santos-Fonseca RS, Cruzata-Bravo J, Lopes-Cá ND

Language: Spanish
References: 18
Page: 1-11
PDF size: 285.51 Kb.


ABSTRACT

Introduction: Chronic urticaria is a heterogeneous demarcated skin disease characterized by the development of wheals or hives.
Objective: Determination of the clinical characteristics and the pharmacological treatment indicated in patients diagnosed with chronic urticaria.
Method: A quantitative, prospective, observational and descriptive study was conducted in a total of 48 patients (the universe) diagnosed with chronic urticaria, Main Military Hospital, Guinea-Bissau, 2018-2020. The following variables were used: age, sex, type of urticaria, time of evolution, comorbidity and treatment used in the first and last recorded consultation, as well as disease activity.
vResults: The mean age was 38.52 years with a female predominance. The mean time of evolution of the disease was 4.67 years and 70.83% did not present angioedema. Chronic spontaneous urticaria was the predominant type. cyproheptadine was the treatment most indicated to be used at baseline and at the end of treatment follow-up its use increased. montelukast was the other drug that increased its use at the end of follow-up. With the treatment used disease activity was reduced up to rates recognized as controlled chronic spontaneous urticaria.
Conclusions: Chronic urticaria in Guinea-Bissau has prevalence and clinical manifestations in line with those reported worldwide, with treatment regimens susceptible to modifications depending on the early use of recommended drugs such as cyclosporine or omalizumab.


REFERENCES

  1. Tincopa-Wong ÓW. Urticaria y angioedema: una visión general. Acta Méd Per [Internet]. 2014 [citado 05/01/2022]; 31(2):111-124. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1728-59172014000200008&lng=es1.

  2. Zamitiz-Hernández J, Celio-Murillo R, Torres-Reyes MA, León-Aguilar R, Ramírez-González V. Prevalencia de urticaria crónica en una unidad médica. Rev Alerg Méx [Internet]. 2021 [citado 05/01/2022]; 68(3):174-179. DOI: https://doi.org/10.29262/ram.v68i3.8672.

  3. Herrera-Sánchez DA, Álvarez-Chávez FE, O´Farrill-Romanillos PM. Actividad de la urticaria crónica espontánea en pacientes eutiroideos versus hipotiroideos. Rev Alerg Méx [Internet]. 2020 Jun [citado 05/01/2022]; 67(2):112-118. DOI: https://doi.org/10.29262/ram.v67i2.6353.

  4. Sugrañes-Montalván A, Barreto-Suarez E, Quesada-Leyva L. Urticaria por frío en un adolescente. MEDISAN [Internet]. 2019 [citado 05/01/2022]; 23(3):[aproximadamente 8 p.]. Disponible en: http://www.medisan.sld.cu/index.php/san/article/view/23184.

  5. Dabija D, Tadi P. Chronic Urticaria. Stat Pearls [Internet] 2019 [citado 05/01/2022]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK555910/5.

  6. Aguilera-Insunza R, Correa H, Díaz C, Marinovic MA, Valenzuela F. Guía clínica chilena de urticaria crónica espontánea. Rev Méd Chile [Internet]. 2018 [citado 05/01/2022]; 146(11):1334-1342. DOI: http://dx.doi.org/10.4067/S0034-988720180011013346.

  7. Sánchez-Villalobos JY, Huerta-Romero J. Urticaria aguda en pediatría. Bol Clin Hosp Inf Edo Son [Internet]. 2019 [citado 05/01/2022]; 36(2):72-79. Disponible en: https://www.medigraphic.com/pdfs/bolclinhosinfson/bis-2019/bis192d.pdf7.

  8. Cruz-Hernández A, Caballero-López CG, López-García AI, Rivero-Yeverino D, Arana-Muñoz O, Papaqui-Tapia JS, et al. Prevalencia de la urticaria crónica y su perfil clínico epidemiológico. Alerg Asma Inmunol Ped [Internet]. 2019 [citado 05/01/2022]; 28(2):47-50. Disponible en: https://www.medigraphic.com/pdfs/alergia/al-2019/al192c.pdf8.

  9. Silvestre-Salvador JF, Serrano-Manzano M, Serra-Baldrich E, Palacios-Martinez D, Gomez-de la Fuentes E, Heras-Hito JA, et al. Recomendaciones para el manejo de la urticaria en Atención Primaria. Medicina de Familia. SEMERGEN [Internet]. 2020 [citado 05/01/2022]; 46(4):270-276. DOI: http://dx.doi.org/10.1016/j.semerg.2019.12.0069.

  10. Alcántara Villar M, Armario Hita JC, Cimbollek S, Fernández Ballesteros MD, Galán Gutiérrez M, Hernández Montoya C, et al. Revisión de las últimas novedades en el manejo del paciente con urticaria crónica: Consenso multidisciplinar de la comunidad autónoma de Andalucía. Actas Dermosifiliogr [Internet]. 2020 [citado 05/01/2022]; 111(3):222-228. DOI: http://dx.doi.org/doi.org/10.1016/j.ad.2019.04.00910.

  11. Coronado B, Ochoa-García IV, Torres-Lozano C, Quintero-Ramos A, Ortega-Cisneros M. Frecuencia y caracterización clínica de la urticaria crónica en un hospital de tercer nivel. Rev Alerg Méx [Internet]. 2021 Jun [citado 05/01/2022]; 68(2):94-100. DOI: http://dx.doi.org/doi.org/10.29262/ram.v658i2.81811.

  12. Sedó-Mejía G, Lotz-Esquivel S, Monge-Ortega OP, Pino-García C. Perfil clínico de los pacientes con urticaria crónica en un hospital de tercer nivel de atención del sistema de seguridad social de Costa Rica. Rev Alerg Méx [Internet]. 2021 [citado 05/01/2022]; 68(4):225-232. DOI: https://doi.org/10.29262/ram.v68i4.88112.

  13. Coelho Dias GA, Cunha Coelho F, Filippo P, Lacerda Pedrazzi D, Nogueira Arraes AC, Perelló MI, et al. Clinical experience of a chronic urticaria university referral center. Eur Ann Aller Clin Immunol [Internet]. 2021 [citado 31/08/2022]; 52(3):112-120. DOI: http://dx.doi.org/10.23822/EurAnnACI.1764-1489.10313.

  14. Gómez RM, Jares E, Borges MS, Baiardini I, Walter-Canonica G, Passalacqua G, et al. Latin American chronic urticaria registry (CUR) contribution to the understanding and knowledge of the disease in the region. World Allergy Organ J [Internet]. 2019 [citado 31/08/2022]; 12(6):100042. DOI: https://doi.org/10.1016/j.waojou.2019.10004214.

  15. Maurer M, Houghton K, Costa C, Dabove F, Ensina LF, Giménez-Arnau A, et al. Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study. World Allergy Organ J [Internet]. 2018 [citado 05/01/2022]; 11(1):32. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30464782/15.

  16. Sussman G, Abuzakouk M, Bérard F, Canonica W, Oude-Elberink HO, Giménez-Arnau A, et al. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU. Allergy [Internet]. 2018 [citado 05/01/2022]; 73(8):1724-1734. DOI: https://doi.org/10.1111/all.1343016.

  17. Marín-Cabañas I, Berbegal-de Gracia L, de León-Marrero F, Hispán P, Silvestre JF. Management of chronic spontaneous urticariain routine clinical practice following the EAACI/GA(2)LEN/EDF/WAO guidelines. Actas Dermosifiliogr [Internet]. 2017 [citado 05/01/2022]; 108(4):346-353. DOI: https://doi.org/10.1016/j.ad.2016.12.01217.

  18. Salman A, Demir G, Bekiroglu N. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data. Dermatol Ther [Internet]. 2019 [citado 05/01/2022]; 32(4):e12975. DOI: https://doi.org/10.1111/dth.1297518.




2020     |     www.medigraphic.com